Precautions during Gilteritinib Treatment

Precautions during Gilteritinib Treatment

FLT3 mutations are not static. Many patients may not test positive for an FLT3 mutation at initial diagnosis, but the mutation may appear as the disease progresses or after relapse. Therefore, repeated genetic testing at different stages of treatment is very important. Doctors typically detect mutations using bone marrow or blood samples, and results can be available within 2 to 3 business days. Only after determining the mutation status can doctors develop the most appropriate personalized treatment plan for the patient. Relying solely on initial diagnosis results may cause patients to miss the opportunity to use targeted therapies (such as XOSPATA). So, take the initiative to ask your doctor: Have you retested me for FLT3 mutations upon disease relapse or progression? This simple question could change the entire direction of treatment.

What is AML?

AML is a type of blood cancer that originates in the bone marrow. The bone marrow is the body's factory for producing red blood cells, white blood cells, and platelets. When a person has AML, the bone marrow produces a large number of abnormal blood cells called "blasts" or "leukemia cells." These cells do not function properly and crowd out healthy blood cells. AML is one of the most common types of leukemia in adults, with an estimated 20,800 new cases per year in the United States. Although AML primarily affects older adults, younger people can also develop the disease. Understanding the basic characteristics of AML can help patients and their families face the upcoming treatment challenges with greater confidence.

Daily Precautions for Taking Gilteritinib

As a caregiver, in terms of communication, you can proactively ask your doctor the following questions: How can we monitor treatment effectiveness at home? What tests need to be arranged before treatment? Who can we contact in an emergency when the doctor is not available? Can you recommend a support group? Second, help the patient keep a side effect diary and accurately relay the information during medical visits. At the same time, do not neglect your own physical and mental health: continue to maintain some personal hobbies, build your own support network of family and friends, and actively seek help from the care team when facing difficulties. Make good use of various caregiver resources and support organizations.